Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The Food and Drug Administration has approved GLP-1 medications for treating type 2 diabetes and obesity
It encodes the SDC2 protein, which plays a role in the interaction regulation of cell-environment interactions
These VEGF-independent pathways may aid resistance to VEGF-targeted therapies, highlighting the need to identify and target alternative pro-angiogenic signals
Statements Author contributions SN: Writing original draft, Writing review & editing, Validation, Supervision, Conceptualization, Data curation
US$ 29.57
US$ 25.38
US$ 23.07
